In the rigorous landscape of pharmaceutical research and development, the quality and consistency of chemical intermediates are non-negotiable. For scientists investigating cellular pathways critical to diseases like gastric cancer, compounds that modulate specific signaling cascades are essential tools. IWP-2, identified by CAS No.: 686770-61-6, stands as a potent WNT-3A inhibitor, playing a vital role in cancer research by targeting the Wnt/β-catenin pathway.

The scientific utility of IWP-2 is well-documented. Its efficacy in inhibiting WNT-3A translates into observable effects on cancer cells, including a reduction in proliferation, migration, and invasion. This compound also demonstrates an ability to increase caspase 3/7 activity, a key indicator of apoptosis. By modulating these cellular processes, IWP-2 offers valuable insights for researchers aiming to develop new therapeutic agents for various cancers. Its precise function makes it a sought-after pharmaceutical intermediate for advanced R&D projects.

For procurement managers and R&D scientists, securing a reliable supply of IWP-2 is crucial. When you decide to buy IWP-2, it’s imperative to partner with reputable manufacturers and suppliers. Key considerations include product purity (often specified as 97% min.), clear physical characteristics (typically a solid powder), and efficient solubility in common research solvents like DMSO. For global R&D teams, seeking competitive pricing and consistent availability from manufacturers in China can be a strategic advantage.

If your research projects require a dependable WNT-3A inhibitor, exploring options for IWP-2 is a logical next step. Engaging with a trusted supplier to obtain a quote for your required quantities ensures you receive a high-quality product that meets your research specifications. Investing in a reliable source for IWP-2 will directly support the progress and success of your critical cancer research initiatives.